Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IGM BIOSCIENCES, INC.

(IGMS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IGM Biosciences : Names New Chief Medical Officer

07/29/2021 | 05:50pm EDT


© MT Newswires 2021
All news about IGM BIOSCIENCES, INC.
09/07IGM Biosciences to Participate in Three Upcoming Investor Conferences
GL
08/26IGM BIOSCIENCES : Morgan Stanley Starts IGM Biosciences at Overweight With $100 ..
MT
08/16IGM BIOSCIENCES : Wedbush Lifts IGM Biosciences' Price Target to $82 From $77; N..
MT
08/10IGM BIOSCIENCES : RBC Capital Adjusts IGM Biosciences PT to $110 From $107, Main..
MT
08/10IGM BIOSCIENCES : Posts Wider Q2 Loss; Files for Up to $400 Million Mixed-Securi..
MT
08/09IGM BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial..
AQ
08/09IGM BIOSCIENCES : Announces Second Quarter 2021 Financial Results and Provides C..
AQ
08/09IGM BIOSCIENCES : Management's Discussion and Analysis of Financial Condition an..
AQ
08/09Igm Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended J..
CI
08/04IGM BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
More news
Analyst Recommendations on IGM BIOSCIENCES, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -170 M - -
Net cash 2021 230 M - -
P/E ratio 2021 -14,7x
Yield 2021 -
Capitalization 2 399 M 2 399 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 144
Free-Float 45,4%
Chart IGM BIOSCIENCES, INC.
Duration : Period :
IGM Biosciences, Inc. Technical Analysis Chart | IGMS | US4495851085 | MarketScreener
Technical analysis trends IGM BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 74,82 $
Average target price 103,00 $
Spread / Average Target 37,7%
EPS Revisions
Managers and Directors
Fred M. Schwarzer President, Chief Executive Officer & Director
Misbah Tahir Chief Financial Officer
Michael D. Loberg Chairman
Bruce A. Keyt Chief Scientific Officer
T. S. Harigopal Vice President-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
IGM BIOSCIENCES, INC.-15.26%2 261
BIONTECH SE357.13%90 003
GILEAD SCIENCES, INC.22.43%89 434
REGENERON PHARMACEUTICALS35.20%67 910
WUXI APPTEC CO., LTD.35.75%65 728
VERTEX PHARMACEUTICALS-20.83%48 539